Big Pharma’s Partnering Process: An Insight Into The Nitty-Gritty
Executive Summary
Amid ongoing interest in accessing innovative assets, including those from South Korea, big pharma participants at a recent symposium in Seoul shared the ins and outs of the complex partnering process.
You may also be interested in...
Korea 2017 Review: Biosimilar Advances, R&D Progress Restore Confidence
Strong global advances in biosimilars and progress in new drug development as well as clampdowns on illegal rebate payments have dominated headlines in South Korea in 2017.
Korea 2017 Review: Biosimilar Advances, R&D Progress Restore Confidence
Strong global advances in biosimilars and progress in new drug development as well as clampdowns on illegal rebate payments have dominated headlines in South Korea in 2017.
J&J’s Wu On Nurturing Innovation In Asia
Dong Wu, head of J&J Innovation, Asia Pacific, outlines to Scrip the group’s partnering approach in South Korea and the Asia Pacific in general. He also offers some tips to Korean companies that are keen to pursue global partnerships.